Toshio Doi

6.0k citations

169 papers · 4.9k indexed · h-index 37

Impact in

Nephrology top 0.2%
- Chronic Kidney Disease and Diabetes
- Renal Diseases and Glomerulopathies
Clinical Biochemistry top 0.2%
- Advanced Glycation End Products research

Papers in ⓘ

Nephrology 67
- Renal Diseases and Glomerulopathies 38
- Chronic Kidney Disease and Diabetes 35
- Dialysis and Renal Disease Management 15
Clinical Biochemistry 11
- Advanced Glycation End Products research 9

Co-authors: Kojiro Nagai (56 shared papers)Toru Kita (24 shared papers)Hidenori Arai (23 shared papers)Hideharu Abe (50 shared papers)Atsushi Fukatsu (20 shared papers)Liliane J. Striker (5 shared papers)Takeshi Matsubara (19 shared papers)Noriyuki Iehara (16 shared papers)
Journals: Journal of Biological Chemistry (11 papers)PLoS ONE (9 papers)The Nephron journals/Nephron journals (7 papers)Journal of Clinical Investigation (6 papers)The Journal of Medical Investigation (6 papers)
Partner nations: Japan United States United Kingdom

In The Last Decade

Toshio Doi

165 papers receiving 4.7k citations

Peers

Countries citing papers authored by Toshio Doi

Since Specialization

Citations

This map shows the geographic impact of Toshio Doi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toshio Doi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toshio Doi more than expected).

Fields of papers citing papers by Toshio Doi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Toshio Doi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toshio Doi. The network helps show where Toshio Doi may publish in the future.

Co-authors

The 25 scholars most cited alongside Toshio Doi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Toshio Doi Line = papers co-authored together Toshio Doi links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Showing the 20 most-cited of 169 papers — load more, or switch the sort, to bring in the rest.

#	Work
1	Development and prevention of advanced diabetic nephropathy in RAGE-overexpressing mice Journal of Clinical Investigation ·Yasuhiko Yamamoto, Ichiro Kato, Toshio Doi, Hideto Yonekura, Seiji Ohashi, Masayoshi Takeuchi, Takuo Watanabe, Sho‐ichi Yamagishi, Shigeru Sakurai, Shin Takasawa, Hiroshi Okamoto, Hiroshi Yamamoto	2001	409
2	Progressive glomerulosclerosis develops in transgenic mice chronically expressing growth hormone and growth hormone releasing factor but not in those expressing insulinlike growth factor-1. PubMed ·Toshio Doi, Liliane J. Striker, Carol J. Quaife, F. Conti, R D Palmiter, Richard R. Behringer, Ralph L. Brinster, (unknown)	1988	260
3	RAGE Control of Diabetic Nephropathy in a Mouse Model Diabetes ·K.M. Myint, Yasuhiko Yamamoto, Toshio Doi, Ichiro Kato, Ai Harashima, Hideto Yonekura, Takuo Watanabe, Harumichi Shinohara, Masayoshi Takeuchi, Koichi Tsuneyama, Noriyoshi Hashimoto, Masahide Asano, Shin Takasawa, Hiroshi Okamoto, Hiroshi Yamamoto	2006	220
4	Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. Journal of Clinical Investigation ·Karen Mackay, Liliane J. Striker, Joseph Stauffer, Toshio Doi, Lawrence Y. Agodoa, (unknown)	1989	205
5	Inhibition of MCP-1/CCR2 pathway ameliorates the development of diabetic nephropathy Biochemical and Biophysical Research Communications ·Hiroshi Kanamori, Takeshi Matsubara, Akira Mima, Eriko Sumi, Kojiro Nagai, Toshikazu Takahashi, Hideharu Abe, Noriyuki Iehara, Atsushi Fukatsu, Hiroshi Okamoto, Toru Kita, Toshio Doi, Hidenori Arai	2007	140
6	Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy Kidney International ·Kojiro Nagai, Takeshi Matsubara, Akira Mima, Eriko Sumi, Hiroshi Kanamori, Noriyuki Iehara, Atsushi Fukatsu, Motoko Yanagita, Toru Nakano, Yoshikazu Ishimoto, Toru Kita, Toshio Doi, Hidenori Arai	2005	129
7	A Vitamin D Analog Ameliorates Glomerular Injury on Rat Glomerulonephritis American Journal Of Pathology ·Kojiro Makibayashi, Mitsuyoshi Tatematsu, Michinori Hirata, Naoshi Fukushima, Kenichiro Kusano, Seiji Ohashi, Hideharu Abe, Kogo Kuze, Atsushi Fukatsu, Toru Kita, Toshio Doi	2001	115
8	525 Safety and efficacy of pembrolizumab (MK-3475) in patients (pts) with advanced biliary tract cancer: Interim results of KEYNOTE-028 European Journal of Cancer ·Yung‐Jue Bang, Toshio Doi, Filippo de Braud, Sarina A. Piha‐Paul, Antoine Hollebecque, Albiruni Ryan Abdul Razak, Chieh‐Chung Lin, Peter Ott, Andy He, Sammy Yuan, Minori Koshiji, K. H. Brian Lam, Rakesh Aggarwal	2015	112
9	Regulation of apolipoprotein B production and secretion in response to the change of intracellular cholesteryl ester contents in rabbit hepatocytes Journal of Biological Chemistry ·M Tanaka, Hisato Jingami, Haruhisa Otani, M. Cho, Yukihiko Ueda, Hiroyuki Arai, Yutaka Nagano, Toshio Doi, Masataka Yokode, Tomoyuki Kita	1993	96
10	Gas6 Regulates Mesangial Cell Proliferation through Axl in Experimental Glomerulonephritis American Journal Of Pathology ·Motoko Yanagita, Hidenori Arai, Kenji Ishii, Toru Nakano, Kazumasa Ohashi, Kensaku Mizuno, Brian Varnum, Atsushi Fukatsu, Toshio Doi, Toru Kita	2001	91
11	Expression Levels of Renal Organic Anion Transporters (OATs) and Their Correlation with Anionic Drug Excretion in Patients with Renal Diseases Pharmaceutical Research ·Yuji Sakurai, Hideyuki Motohashi, Harumasa Ueo, Satohiro Masuda, Hideyuki Saito, Masahiro Okuda, Noriko Mori, Motokazu Matsuura, Toshio Doi, Atsushi Fukatsu, Osamu Ogawa, Ken‐ichi Inui	2004	87
12	Growth Arrest-specific Gene 6 Is Involved in Glomerular Hypertrophy in the Early Stage of Diabetic Nephropathy Journal of Biological Chemistry ·Kojiro Nagai, Hidenori Arai, Motoko Yanagita, Takeshi Matsubara, Hiroshi Kanamori, Toru Nakano, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Toshio Doi	2003	86
13	Gas6 Induces Mesangial Cell Proliferation via Latent Transcription Factor STAT3 Journal of Biological Chemistry ·Motoko Yanagita, Hidenori Arai, Toru Nakano, Kazumasa Ohashi, Kensaku Mizuno, Atsushi Fukatsu, Toshio Doi, Toru Kita	2001	82
14	Type IV Collagen Is Transcriptionally Regulated by Smad1 under Advanced Glycation End Product (AGE) Stimulation Journal of Biological Chemistry ·Hideharu Abe, Takeshi Matsubara, Noriyuki Iehara, Kojiro Nagai, Toshikazu Takahashi, Hidenori Arai, Toru Kita, Toshio Doi	2004	78
15	Glomerulosclerosis in mice transgenic for growth hormone. Increased mesangial extracellular matrix is correlated with kidney mRNA levels. The Journal of Experimental Medicine ·Toshio Doi, Liliane J. Striker, Koji Kimata, E P Peten, Yasuhiro Yamada, (unknown)	1991	78
16	Phosphorylation of Nephrin Triggers Its Internalization by Raft-Mediated Endocytosis Journal of the American Society of Nephrology ·Xiaosong Qin, Hiroyasu Tsukaguchi, Akemi Shono, Akitsugu Yamamoto, Hidetake Kurihara, Toshio Doi	2009	78
17	Essential role of Gas6 for glomerular injury in nephrotoxic nephritis Journal of Clinical Investigation ·Motoko Yanagita, Yoshikazu Ishimoto, Hidenori Arai, Kojiro Nagai, Tsuyoshi Ito, Toru Nakano, David J. Salant, Atsushi Fukatsu, Toshio Doi, Toru Kita	2002	78
18	Angiotensin II-dependent Src and Smad1 signaling pathway is crucial for the development of diabetic nephropathy Laboratory Investigation ·Akira Mima, Takeshi Matsubara, Hidenori Arai, Hideharu Abe, Kojiro Nagai, Hiroshi Kanamori, Eriko Sumi, Toshikazu Takahashi, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Toshio Doi	2006	68
19	Essential role of Gas6 for glomerular injury in nephrotoxic nephritis Journal of Clinical Investigation ·Motoko Yanagita, Yoshikazu Ishimoto, Hidenori Arai, Kojiro Nagai, Tsuyoshi Ito, Toru Nakano, David J. Salant, Atsushi Fukatsu, Toshio Doi, Toru Kita	2002	67
20	Expression of Smad1 is directly associated with mesangial matrix expansion in rat diabetic nephropathy Laboratory Investigation ·Takeshi Matsubara, Hideharu Abe, Hidenori Arai, Kojiro Nagai, Akira Mima, Hiroshi Kanamori, Eriko Sumi, Toshikazu Takahashi, Motokazu Matsuura, Noriyuki Iehara, Atsushi Fukatsu, Toru Kita, Toshio Doi	2006	64

About Toshio Doi

Toshio Doi is a scholar working on Nephrology, Clinical Biochemistry, Pathology and Forensic Medicine, Hepatology and Immunology, having authored 169 papers that have together received 4.9k indexed citations. Recurring topics across this work include Renal Diseases and Glomerulopathies (38 papers), Chronic Kidney Disease and Diabetes (35 papers), Dialysis and Renal Disease Management (15 papers), Spine and Intervertebral Disc Pathology (14 papers), TGF-β signaling in diseases (13 papers), Phagocytosis and Immune Regulation (10 papers), Spinal Fractures and Fixation Techniques (10 papers) and Advanced Glycation End Products research (9 papers). The work is most often cited by research in Nephrology (1.5k citations), Clinical Biochemistry (829 citations), Endocrinology, Diabetes and Metabolism (839 citations), Immunology (725 citations) and Pathology and Forensic Medicine (596 citations). Toshio Doi has collaborated with scholars based in Japan, United States and United Kingdom. Frequent co-authors include Kojiro Nagai, Toru Kita, Hidenori Arai, Hideharu Abe, Atsushi Fukatsu, Liliane J. Striker, Takeshi Matsubara, Noriyuki Iehara, Yasuhiko Yamamoto and Hiroshi Yamamoto. Their work appears in journals such as Journal of Biological Chemistry, PLoS ONE, The Nephron journals/Nephron journals, Journal of Clinical Investigation and The Journal of Medical Investigation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact